Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib|DRUG: capecitabine
Sponsor: Novartis Pharmaceuticals